Vanja Podrascanin, MD

Research Fellow Mayo Clinic Rochester, Lab: TELL International, Surgical resident at Clinic Wiener Neustadt

[Vanja Podrascanin, MD @vanjapod]

💡 Can we really lump all G2 PNETs together?

With a Ki-67 range from 3–20%, G2 covers a 7-fold proliferative spectrum — can that really be one disease?

⬇️ Take a look below and read more in our latest publication in Annals of Surgical Oncology:
🔗 https://t.co/3kOnTWiq5q

[Thor Halfdanarson @OncoThor]

Should primary pancreatic NETs be resected at the time of hepatic debulking in asymptomatic patients with metastatic pNETs? Perhaps not... In this retrospective study, no significant difference in overall survival whether primary tumor was removed or not

https://t.co/X89XTQ5eqW